Insights & News

Industry Perspectives from the Ground

Regulatory updates, market analysis, scientific commentary, and company news — written for pharmaceutical buyers, investors, and industry partners.

Regulatory

Policy & Licensing

Market

Global Pharma Cannabis

Science

Research & Developmen

Company

HMF Updates

Ghana NACOC Act 1100 · LI 2475 · February 2026
Pharmaceutical Cannabis · EU Market
GACP · GMP · ALCOA+ Standards
West Africa · First Licensed Producer
Series A · Initial Capital Secured
50,000 kg Pilot Capacity
EU-GMP Development Roadmap
Pharmaceutical-Grade Dried Flower
Export Compliant — EU · Canada · UK
Third-Party Tested Every Batch
Ghana NACOC Act 1100 · LI 2475 · February 2026
Pharmaceutical Cannabis · EU Market
GACP · GMP · ALCOA+ Standards
West Africa · First Licensed Producer
Series A · Initial Capital Secured
50,000 kg Pilot Capacity
EU-GMP Development Roadmap
Pharmaceutical-Grade Dried Flower
Export Compliant — EU · Canada · UK
Third-Party Tested Every Batch

Latest Posts

Insights from HMF Ltd

Ghana NACOC LI 2475 regulatory framework

Ghana's NACOC LI 2475: What the New Pharmaceutical Cannabis Licensing Framework Means for Global Supply Chains

Ghana's Narcotic Control Commission activated Licensing Instrument 2475 in February 2026 — the first formal pharmaceutical cannabis regulatory framework in West Africa. We break down what it authorises, who qualifies, and why it matters for EU and Canadian pharmaceutical buyers seeking compliant, diversified supply.

Pharmaceutical cannabis market

The $133B Pharmaceutical Cannabis Market: Where Africa Fits in the Global Supply Chain

Global pharmaceutical cannabis demand is growing faster than compliant supply can keep pace. We examine where African production fits in the supply gap — and why first-mover positioning matters more than scale in 2026.

GACP vs GMP compliance

GACP vs GMP: Understanding the Compliance Ladder for Pharmaceutical Cannabis Raw Materials

Many cannabis producers claim compliance. Few understand the distinction between Good Agricultural and Collection Practices and full Good Manufacturing Practice — and what each means for pharmaceutical buyers integrating cannabis raw materials.

HMF Ltd Ghana cannabis cultivation

HMF Ltd Receives NACOC Licence Under Ghana's LI 2475 — A Historic First for West Africa

Hemp Medicinal Farm Ltd is among the first companies to receive a pharmaceutical cannabis production licence under Ghana's new NACOC framework. Here is what it means for our operations, our partners, and our Series A raise.

EU pharmaceutical cannabis compliance

What EU Pharmaceutical Manufacturers Require from a Cannabis Raw Material Supplier in 2026

We surveyed EU pharmaceutical procurement requirements for cannabis raw materials — from GACP documentation to batch testing formats, shelf life claims, and import authorisation processes. A practical guide for African producers.

Ghana Africa agricultural advantage

Why Ghana's Equatorial Climate Gives African Cannabis Producers a Structural Cost Advantage Over Europe

Year-round cultivation. Natural light. Lower operational costs. We examine the production economics that make a Ghana-origin pharmaceutical cannabis supply chain fundamentally different from European alternatives.

Cannabinoid profiling pharmaceutical

Cannabinoid Profile Consistency: Why Batch-to-Batch Variance Is the Critical Metric for Pharmaceutical Buyers

A pharmaceutical manufacturer needs to know that the cannabis raw material arriving in batch 47 performs identically to batch 1. We explain how HMF Research's phenotype stabilisation programme delivers this consistency.

Upload Post Image

Your Next Post Title Here

Add your own post via WordPress Admin → Posts → Add New. It will automatically appear in this grid.

Upload Post Image

Your Next Post Title Here

Add your own regulatory update, market analysis, or company news post via WordPress Admin → Posts → Add New.

Stay Informed

Regulatory Updates & Industry Insights

Subscribe for pharmaceutical cannabis regulatory news, HMF company updates, and market intelligence — delivered to your inbox.

Ready to Go Beyond the Articles?

Pharmaceutical buyers, investors, and research partners can arrange a direct briefing with the HMF Ltd team.